Skip to content
Search for:
About Us
Mission & Vision
Leadership
Board of Directors
Scientific Advisors
Pipeline
Careers & Culture
Contact Us
Disease Areas & Tests
Innovative Diagnostic Portfolio to Manage the Patient Journey
Our industry-leading GI diagnostic portfolio provides actionable results across the patient journey. From diagnosis to treatment, disease monitoring and through remission, the Prometheus suite of tests are purpose-built to confidently guide patient care decisions.
Precision-Guided Dosing
About PredictrPK
Infliximab
Induction
Maintenance
Adalimumab
Therapeutic Drug Monitoring
Anser IFX
Anser ADA
Anser VDZ
Anser UST
Inflammatory Bowel Disease
Monitr
IBD sgi Diagnostic
Crohn’s Prognostic
RiskImmune
Thiopurine Management
TPMT Genetics
TPMT Enzyme
Thiopurine Metabolites
Celiac
Celiac Plus
Celiac Genetics
Celiac Serology
Additional Testing
FIBROSpect HCV
FIBROSpect NASH
LactoTYPE
News & Events
News
Events
Videos
Healthcare Providers
Patients
Search for:
About Us
Mission & Vision
Leadership
Board of Directors
Scientific Advisors
Pipeline
Careers & Culture
Contact Us
Disease Areas & Tests
Innovative Diagnostic Portfolio to Manage the Patient Journey
Our industry-leading GI diagnostic portfolio provides actionable results across the patient journey. From diagnosis to treatment, disease monitoring and through remission, the Prometheus suite of tests are purpose-built to confidently guide patient care decisions.
Precision-Guided Dosing
About PredictrPK
Infliximab
Induction
Maintenance
Adalimumab
Therapeutic Drug Monitoring
Anser IFX
Anser ADA
Anser VDZ
Anser UST
Inflammatory Bowel Disease
Monitr
IBD sgi Diagnostic
Crohn’s Prognostic
RiskImmune
Thiopurine Management
TPMT Genetics
TPMT Enzyme
Thiopurine Metabolites
Celiac
Celiac Plus
Celiac Genetics
Celiac Serology
Additional Testing
FIBROSpect HCV
FIBROSpect NASH
LactoTYPE
News & Events
News
Events
Videos
Healthcare Providers
Patients
About Us
Mission & Vision
Leadership
Board of Directors
Scientific Advisors
Pipeline
Careers & Culture
Contact Us
Disease Areas & Tests
Innovative Diagnostic Portfolio to Manage the Patient Journey
Our industry-leading GI diagnostic portfolio provides actionable results across the patient journey. From diagnosis to treatment, disease monitoring and through remission, the Prometheus suite of tests are purpose-built to confidently guide patient care decisions.
Precision-Guided Dosing
About PredictrPK
Infliximab
Induction
Maintenance
Adalimumab
Therapeutic Drug Monitoring
Anser IFX
Anser ADA
Anser VDZ
Anser UST
Inflammatory Bowel Disease
Monitr
IBD sgi Diagnostic
Crohn’s Prognostic
RiskImmune
Thiopurine Management
TPMT Genetics
TPMT Enzyme
Thiopurine Metabolites
Celiac
Celiac Plus
Celiac Genetics
Celiac Serology
Additional Testing
FIBROSpect HCV
FIBROSpect NASH
LactoTYPE
News & Events
News
Events
Videos
Healthcare Providers
Patients
Licensure
prometheuslabs
2024-07-31T11:36:24-07:00
Licensure
California License
CAP License
CLIA Certificate
Maryland non expiring
New York State License
Pennsylvania License
Rhode Island
Page load link
Go to Top
